Clinical Trial Update: The Effect of empagliFlozin on Platelet Function profilEs in diabetiC patienTs - The EFFECT Study. [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating empagliflozin's effect on platelet function in diabetic patients has completed; results were posted on 2024-09-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: The University of The West Indies | Conditions: Platelet Dysfunction Due to Drugs | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-09-03